Wed, Sep 23, 11:30 AM - 12:45 PM
TBD
Scientific and Regulatory Considerations for Developing COVID-19 Vaccine During Pandemic
Panel Discussion (302305)
*
Peter Gilbert, University of Washington
*
Ian Hirsch, AstraZeneca
*
Kenneth Koury, Pfizer, Inc.
*
Jinzhong Lin, Fudan University, Shanghai RNAcure biopharma co., Ltd
*
John Scott, US Food and Drug Administration
*
Andrew Thomson, EMA Taskforce Dedicated to Data, Analytics, and Methodology
